Malnutrition and Cachexia — Clinical Documentation Guide (2026)

🔍 Definition

Malnutrition is a broad term encompassing deficiencies, excesses, or imbalances in a person’s intake of energy and/or nutrients. In clinical coding, malnutrition most often refers to undernutrition — inadequate intake of protein, calories, or both — resulting in measurable physiological consequences. The American Society for Parenteral and Enteral Nutrition (ASPEN) and the American Academy of Nutrition and Dietetics (AND) jointly published consensus diagnostic criteria (the ASPEN/AND Consensus Statement, 2012, updated 2021) that define malnutrition by etiologic category and severity using observable clinical indicators including weight loss, energy intake, body composition, functional status, and inflammatory markers.

Malnutrition is classified in ICD-10-CM under categories E40–E46 and ranges from specified severe forms (E40 Kwashiorkor, E41 Nutritional marasmus) to unspecified protein-calorie malnutrition (E46). Severity coding is critical: the difference between E44.1 (mild) and E43 (severe) represents the difference between no risk adjustment credit and HCC 48 with a RAF weight of approximately 1.018 — a difference worth $1,500–$3,000+ in annual per-member revenue under CMS-HCC Model v28.

Cachexia (ICD-10-CM R64) is a complex metabolic syndrome associated with underlying chronic illness and characterized by loss of muscle (with or without fat mass), elevated inflammatory markers, anorexia, and functional decline. Unlike starvation-related malnutrition, cachexia is driven by an inflammatory response and is not fully reversible with nutritional supplementation alone. Cachexia must be linked to a documented underlying disease — neoplastic, cardiac, pulmonary, renal, or infectious — to be coded properly. R64 maps to HCC 48 in v28.

Sarcopenia (M62.84, FY2024 new code, active in FY2026) is defined as age-related progressive loss of skeletal muscle mass and function. While sarcopenia often coexists with malnutrition and cachexia, it does not map to an HCC and is primarily used for geriatric coding and quality metrics.

🗂️ Alternative Terminology

Clinicians and dietitians use a wide variety of terms for these conditions. Coders and CDI specialists must recognize all of them and map appropriately to ICD-10-CM codes.

🩺 Signs & Symptoms

The ASPEN/AND consensus criteria identify six clinical characteristics used to diagnose and grade malnutrition. At least two must be present for diagnosis:

1. Insufficient energy intake — documented reduction in intake relative to estimated needs
2. Weight loss — measured or reported over defined timeframe
3. Loss of muscle mass — assessed by physical examination, DEXA, or validated tools (SGA, MNA)
4. Loss of subcutaneous fat — orbital, triceps, chest wall wasting on physical exam
5. Localized or generalized fluid accumulation — may mask true weight loss (edema in kwashiorkor)
6. Diminished functional status — reduced grip strength, declining performance status

Additional clinical indicators by severity:

Cachexia-specific findings: involuntary weight loss >5% in 12 months (or BMI <20) plus ≥3 of the following: decreased muscle strength, fatigue, anorexia, low fat-free mass index, elevated inflammatory markers (CRP >5 mg/L, IL-6 >4 pg/mL), anemia, low serum albumin (<3.2 g/dL). Per the 2011 international consensus definition, cachexia has three stages: pre-cachexia, cachexia, and refractory cachexia.

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

Documentation of malnutrition must meet ICD-10-CM Official Guidelines Section I.C.4 (Endocrine, Nutritional, and Metabolic Diseases). The diagnosis must be documented by a physician or qualified provider — dietitian documentation may support the query but cannot stand alone for coding purposes unless the facility has an approved dietitian scope-of-practice policy. The provider must authenticate (sign or co-sign) a malnutrition diagnosis.

🦴 Anatomy & Pathophysiology

Protein-calorie malnutrition (PCM) develops when energy and/or protein intake chronically fails to meet metabolic demand. The body initially mobilizes glycogen stores, then fat (lipolysis), and finally catabolizes skeletal muscle protein (gluconeogenesis) to maintain vital organ function. Progressive muscle wasting (sarcopenia-like) ensues, accompanied by immune suppression, impaired wound healing, endocrine dysregulation, and multiorgan dysfunction.

Two major PCM phenotypes:

• Marasmus (E41): Predominant caloric deficiency. Body adapts via profound fat and muscle catabolism but maintains serum albumin relatively. Patient appears severely emaciated — “skin and bones.” Low BMI, sunken cheeks, temporal wasting, no edema. Common in chronic starvation, advanced cancer, prolonged NPO states.
• Kwashiorkor (E40): Predominant protein deficiency with relatively adequate caloric intake. Hypoalbuminemia drives oncotic pressure loss → pitting edema, ascites, anasarca. Skin changes (flaky paint dermatosis), hair changes (flag sign — alternating light/dark bands). Patient may appear “well-nourished” due to edema masking weight loss. More common in hospitalized patients on glucose-only fluids.

Cachexia pathophysiology: Driven by pro-inflammatory cytokines — TNF-α, IL-1β, IL-6, IFN-γ — released by the underlying disease (tumor, failing heart, inflamed lung). These cytokines activate ubiquitin-proteasome pathways in skeletal muscle, causing accelerated proteolysis. Unlike starvation, cachexia involves both muscle protein breakdown and impaired anabolism — feeding does not reverse it. The result is disproportionate loss of lean body mass with relative preservation of fat (or simultaneous fat loss in refractory cachexia). Loss of lean mass directly correlates with functional decline, treatment toxicity in cancer, and mortality.

Vitamin deficiencies arise when dietary intake, absorption, or metabolic conversion of specific micronutrients is insufficient. Each deficiency syndrome has a distinct pathophysiology: thiamine (E51) affects cellular energy metabolism; niacin (E52/pellagra) affects NAD+-dependent reactions; vitamin C (E54) impairs collagen cross-linking; vitamin D (E55) disrupts calcium homeostasis and bone mineralization; vitamin K (E56.1) impairs coagulation factor carboxylation.

💊 Medication Impact / Treatment

Several medications influence nutritional status and are relevant to malnutrition/cachexia coding and CDI:

• Corticosteroids: Chronic use causes muscle catabolism, fat redistribution, glucose intolerance, and bone loss — can mask malnutrition or cause steroid-induced myopathy. Document steroid-induced osteoporosis (M81.6) separately if applicable.
• Chemotherapy: Causes mucositis, nausea, anorexia, malabsorption — major driver of cancer cachexia. CDI opportunity: document cachexia (R64 + neoplasm code) when meeting criteria.
• Immunosuppressants (tacrolimus, mycophenolate): GI side effects reduce intake; monitor prealbumin, albumin.
• Diuretics: May deplete potassium, magnesium, and zinc; mask edematous malnutrition in fluid-overloaded patients.
• Proton pump inhibitors (long-term): Reduce vitamin B12 absorption; code E53.8 if deficiency documented.
• Metformin (long-term): Associated with B12 malabsorption — code E53.8 or use drug-induced nutritional deficiency coding.
• Orexigenic agents: Megestrol acetate, dronabinol — used to stimulate appetite in cachexia; do not reverse the underlying inflammatory process.
• Cyanocobalamin (vitamin B12): Administered by injection (J3420, 96372) or oral supplementation for deficiency states (E53.8).
• Vitamin D supplements: Oral calcitriol or ergocalciferol for E55.x deficiencies; IV calcitriol in dialysis patients.
• Parenteral/enteral nutrition (TPN/EN): Primary treatment for severe malnutrition when oral intake is inadequate or impossible. Document indication (malnutrition code) and route (Z93.1 gastrostomy status, Z99.89 dependence).

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

Malnutrition coding is governed by ICD-10-CM Official Guidelines for Coding and Reporting FY2026, Section I.C.4 (Endocrine, Nutritional, and Metabolic Diseases). Key guideline principles:

• Physician authentication required: Coders may not assign a malnutrition diagnosis based solely on clinical indicators (lab values, dietitian assessments) without physician documentation. However, a CDI query resulting in physician confirmation is appropriate and compliant.
• Dietitian documentation: A registered dietitian’s diagnosis of malnutrition (per ASPEN/AND criteria) is valid documentation when authenticated by a physician. Many facilities have policies specifying that physician co-signature or reference to the dietitian’s note constitutes authentication.
• Severity specificity: When malnutrition is documented, the coder should code to the highest level of specificity supported by documentation. “Malnutrition” alone → E46 (unspecified) unless severity is documented or queried.
• Sequencing — inpatient: When malnutrition is the condition established after study to be chiefly responsible for admission, assign as principal diagnosis. When it complicates another condition (e.g., heart failure with cardiac cachexia), sequence the primary condition first and malnutrition/cachexia as secondary.
• Cachexia coding (R64): Assign R64 with the underlying condition as an additional code. The Official Guidelines instruct that cachexia requires documentation of a causative underlying chronic illness. Do not assign R64 without an accompanying etiology.
• Combination codes: ICD-10-CM includes combination codes for some conditions. For example, kwashiorkor with edema is captured entirely within E40 — do not add a separate edema code. Similarly, marasmus (E41) captures the muscle wasting — no additional muscle wasting code is needed.
• BMI codes (Z68.1): Per guidelines, BMI codes may be assigned based on documentation by any clinician (not limited to the physician) since BMI is an objective measurement. Always assign BMI codes as secondary to the underlying nutritional diagnosis.
• Vitamin deficiencies: Code each documented vitamin deficiency individually. If multiple deficiencies coexist, code each separately (e.g., E55.9 vitamin D deficiency + E53.8 B-vitamin deficiency).
• Pressure ulcer + malnutrition: Both conditions should be coded when documented and present. Malnutrition is an external cause/risk factor for pressure ulcer development and non-healing, not a manifestation — code both independently per guidelines.
• Postprocedural malnutrition: When malnutrition arises as a complication of a procedure (e.g., post-bariatric surgery malabsorption, post-esophagectomy), use the appropriate complication code category (T83.x, K91.x) as well as the malnutrition code.

🔢 ICD-10-CM Code Set (FY2026)

All codes verified against the FY2026 ICD-10-CM Tabular List (effective October 1, 2025).

Malnutrition — Protein-Calorie (E40–E46)

Cachexia, Sarcopenia, and Related Wasting Codes

Eating Disorders with Nutritional Consequence

Vitamin and Mineral Deficiencies

BMI, Feeding Support, and Related Status Codes

🔎 Indexing

Use the FY2026 ICD-10-CM Alphabetic Index to confirm code selection. Key index entries:

🏥 CPT (2026)

CPT codes for malnutrition and nutritional support are sourced from the AMA CPT 2026 Professional Edition. Medical Nutrition Therapy (MNT) services are covered by Medicare under specific conditions per Medicare Benefit Policy Manual Chapter 15, §300.

🧾 HCPCS (2026)

HCPCS Level II codes for enteral/parenteral nutrition are governed by CMS DME Coverage Policy Article A52491. Enteral nutrition is covered under Medicare Part B as a DME benefit when the patient has a permanent impairment of the alimentary tract (not simply malnutrition alone — underlying functional impairment is required).

📚 AHA Coding Clinic (Recent Guidance)

The following AHA Coding Clinic references are relevant to malnutrition and cachexia coding. Coders should consult Coding Clinic for the most current guidance; specific editions noted where applicable.

💰 HCC / Risk Adjustment (v28)

Under the CMS-HCC Model v28 (fully transitioned for 2026 Medicare Advantage risk adjustment), malnutrition-related codes present one of the largest CDI opportunities in clinical practice due to their high RAF weights and frequent under-documentation.

✍️ CDI Query Templates

All query templates are designed per ACDIS/AHIMA Guidelines for Compliant Query Practice. Queries must be non-leading, clinically supported, and offer multiple response options including “clinically undetermined” and “not clinically significant.”

🧑‍⚕️ Treatments (Clinical)

Clinical management of malnutrition and cachexia involves a multidisciplinary team approach including the physician, registered dietitian, speech-language pathologist (for dysphagia), pharmacist, and social worker. The following treatment strategies inform coding and documentation:

Nutritional Repletion — Malnutrition

• Oral nutritional supplements (ONS): First-line when patient can eat; high-calorie, high-protein supplements (Ensure Plus, Boost High Protein, Nutren). Titrate to 1.2–2.0 g protein/kg/day. Document supplement type and frequency in physician or nursing notes to support malnutrition severity coding.
• Enteral nutrition (EN): Via nasogastric tube (NGT, short-term) or PEG/G-tube (long-term, Z93.1) when oral intake is insufficient or unsafe. Formula selection: polymeric (B4150) for intact gut; semi-elemental (B4153) for malabsorption; disease-specific (B4154) for renal/hepatic.
• Parenteral nutrition (PN/TPN): Reserved for patients with non-functional GI tract (short bowel syndrome, bowel obstruction, severe malabsorption). Home PN: HCPCS B4168–B4186; document Z99.89 dependence and underlying malnutrition diagnosis. Transition to EN/oral as soon as clinically feasible.
• Micronutrient supplementation: Concurrent vitamin/mineral deficiency correction — thiamine IV (before glucose in suspected Wernicke’s), B12 IM (J3420), vitamin D oral/IV, vitamin K IV (J3430), zinc supplementation (E60).
• Refeeding syndrome monitoring: Critical for severely malnourished patients beginning nutritional repletion. Hypophosphatemia, hypokalemia, hypomagnesemia can be life-threatening. Monitor electrolytes daily × 72 hours. Code electrolyte disorders (E83.x) if present.

Cachexia Management

• Treat underlying disease: Primary intervention — cancer-directed therapy, optimization of HF management (diuretics, GDMT), COPD exacerbation treatment, dialysis adequacy for renal cachexia.
• Appetite stimulants: Megestrol acetate (FDA-approved for cancer anorexia-cachexia); dronabinol; corticosteroids (short-term). None reverse underlying lean mass loss.
• Exercise/resistance training: Resistance exercise preserves lean mass in cachexia; functional decline is partially mitigated. Document exercise intolerance if present (R53.1 weakness, M62.81 muscle weakness).
• Anti-inflammatory approaches: NSAIDs (celecoxib), omega-3 fatty acids (EPA/DHA) — evidence for attenuating inflammatory cachexia in cancer patients.
• Emerging pharmacotherapy: Anamorelin (ghrelin receptor agonist — available outside US for cancer cachexia), enobosarm (SARM — under investigation). Not currently FDA-approved for cachexia in US.

Sarcopenia Management (M62.84)

• Resistance exercise training (primary intervention) + adequate protein intake (1.2–1.5 g/kg/day per PROT-AGE Study Group)
• Vitamin D supplementation if deficient (E55.9 + Z71.3 counseling)
• Creatine supplementation (adjunct); leucine-enriched essential amino acids

🎓 Patient Education / Summary

The following patient-friendly summary may be used for discharge instructions, care plan documentation, or portal messaging. Documenting patient education supports the E/M medical decision-making record and quality measure compliance.

What is Malnutrition?

Malnutrition means your body is not getting enough protein, calories, or nutrients to work properly. This can happen because you are not eating enough, your body is not absorbing nutrients well, or a serious illness is causing your body to break down muscle and fat faster than you can replace it. Malnutrition can make you feel weak, cause poor wound healing, increase your risk of infection, and slow your recovery from illness or surgery.

Signs to Watch For

• Unintentional weight loss (losing weight without trying)
• Weakness or difficulty walking/performing daily tasks
• Poor appetite or difficulty eating/swallowing
• Swelling in your legs or abdomen (may indicate severe protein deficiency)
• Hair loss, brittle nails, skin problems

What Can You Do?

• Work with a dietitian: A registered dietitian can create a personalized nutrition plan. Ask your doctor for a nutrition consult (CPT 97802/97803).
• Nutritional supplements: Your care team may recommend oral supplements — high-calorie drinks or protein shakes between meals.
• Tube feeding or IV nutrition: If you cannot eat safely or enough by mouth, your team may recommend a feeding tube (gastrostomy, G-tube) or nutrition given through an IV (total parenteral nutrition, TPN).
• Treat the underlying illness: Managing the illness causing weight loss (cancer, heart failure, kidney disease) is key to improving nutrition.
• Follow up: Nutritional status should be reassessed at every visit. Report continued weight loss or poor appetite to your care team immediately.

What is Cachexia?

Cachexia is a more advanced form of wasting that happens in people with serious chronic illnesses like cancer, heart failure, kidney failure, COPD, or HIV. In cachexia, the body breaks down muscle faster than it can be rebuilt — even with good nutrition. Cachexia causes severe weakness, weight loss, fatigue, and poor quality of life. Treatment focuses on controlling the underlying illness, optimizing nutrition, and exercise when possible.

Resources for Patients and Families

• Academy of Nutrition and Dietetics — Malnutrition Patient Guide
• ASPEN Patient and Family Resources on Nutrition Support
• American Cancer Society — Nutrition for People with Cancer

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)